Cargando…
The Current Progress and Future Options of Multiple Therapy and Potential Biomarkers for Muscle-Invasive Bladder Cancer
Bladder cancer is a common disease in men and the elderly. Current treatment paradigms include radical resection of the bladder and lymph nodes or transurethral resection, both supported by chemotherapy and/or radiation. New modalities, such as illumination-based therapies are also being translation...
Autores principales: | Shi, Ying, Mathis, Bryan J., He, Yayun, Yang, Xiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953154/ https://www.ncbi.nlm.nih.gov/pubmed/36831075 http://dx.doi.org/10.3390/biomedicines11020539 |
Ejemplares similares
-
Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise
por: Darwiche, Fadi, et al.
Publicado: (2015) -
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2023) -
The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019) -
Pharmacologic Therapies for Non-Muscle Invasive Bladder Cancer: Current and Future Treatments
por: Goldberg, Ilana P., et al.
Publicado: (2022) -
Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives
por: Kim, In-Ho, et al.
Publicado: (2021)